161 related articles for article (PubMed ID: 9415396)
41. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex.
Luo J; Field SJ; Lee JY; Engelman JA; Cantley LC
J Cell Biol; 2005 Aug; 170(3):455-64. PubMed ID: 16043515
[TBL] [Abstract][Full Text] [Related]
42. Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth.
Blakesley VA; Koval AP; Stannard BS; Scrimgeour A; LeRoith D
J Biol Chem; 1998 Jul; 273(29):18411-22. PubMed ID: 9660809
[TBL] [Abstract][Full Text] [Related]
43. Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells.
Amoui M; Craddock BP; Miller WT
J Endocrinol; 2001 Oct; 171(1):153-62. PubMed ID: 11572799
[TBL] [Abstract][Full Text] [Related]
44. The dominant negative effect of a kinase-defective insulin receptor on insulin-like growth factor-I-stimulated signaling in Rat-1 fibroblasts.
Takata Y; Imamura T; Haruta T; Sasaoka T; Morioka H; Ishihara H; Sawa T; Usui I; Ishiki M; Kobayashi M
Metabolism; 1996 Dec; 45(12):1474-82. PubMed ID: 8969279
[TBL] [Abstract][Full Text] [Related]
45. Identification of major tyrosine phosphorylation sites in the human insulin receptor substrate Gab-1 by insulin receptor kinase in vitro.
Lehr S; Kotzka J; Herkner A; Sikmann A; Meyer HE; Krone W; Müller-Wieland D
Biochemistry; 2000 Sep; 39(35):10898-907. PubMed ID: 10978177
[TBL] [Abstract][Full Text] [Related]
46. Insulin-like growth factor-I receptor and insulin receptor association with a Src homology-2 domain-containing putative adapter.
Wang J; Riedel H
J Biol Chem; 1998 Feb; 273(6):3136-9. PubMed ID: 9452421
[TBL] [Abstract][Full Text] [Related]
47. Functional role of alpha-actinin, PI 3-kinase and MEK1/2 in insulin-like growth factor I receptor kinase regulated motility of human breast carcinoma cells.
Guvakova MA; Adams JC; Boettiger D
J Cell Sci; 2002 Nov; 115(Pt 21):4149-65. PubMed ID: 12356918
[TBL] [Abstract][Full Text] [Related]
48. Substrate specificities of the insulin and insulin-like growth factor 1 receptor tyrosine kinase catalytic domains.
Xu B; Bird VG; Miller WT
J Biol Chem; 1995 Dec; 270(50):29825-30. PubMed ID: 8530377
[TBL] [Abstract][Full Text] [Related]
49. IGF1 receptor signaling pathways.
Hakuno F; Takahashi SI
J Mol Endocrinol; 2018 Jul; 61(1):T69-T86. PubMed ID: 29535161
[TBL] [Abstract][Full Text] [Related]
50. Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains.
He W; Rose DW; Olefsky JM; Gustafson TA
J Biol Chem; 1998 Mar; 273(12):6860-7. PubMed ID: 9506989
[TBL] [Abstract][Full Text] [Related]
51. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells.
Kaliman P; Canicio J; Shepherd PR; Beeton CA; Testar X; Palacín M; Zorzano A
Mol Endocrinol; 1998 Jan; 12(1):66-77. PubMed ID: 9440811
[TBL] [Abstract][Full Text] [Related]
52. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain.
Antonetti DA; Algenstaedt P; Kahn CR
Mol Cell Biol; 1996 May; 16(5):2195-203. PubMed ID: 8628286
[TBL] [Abstract][Full Text] [Related]
53. Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85.
Yamamoto K; Altschuler D; Wood E; Horlick K; Jacobs S; Lapetina EG
J Biol Chem; 1992 Jun; 267(16):11337-43. PubMed ID: 1317864
[TBL] [Abstract][Full Text] [Related]
54. Tumor necrosis factor-alpha (TNF-alpha) inhibits insulin-like growth factor-I (IGF-I) activities in human trophoblast cell cultures through IGF-I/insulin hybrid receptors.
Hashimoto R; Sakai K; Matsumoto H; Iwashita M
Endocr J; 2010; 57(3):193-200. PubMed ID: 20009360
[TBL] [Abstract][Full Text] [Related]
55. IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells.
Baudry A; Lamothe B; Bucchini D; Jami J; Montarras D; Pinset C; Joshi RL
FEBS Lett; 2001 Jan; 488(3):174-8. PubMed ID: 11163767
[TBL] [Abstract][Full Text] [Related]
56. A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK Is generated by alternative splicing of the p85alpha gene.
Inukai K; Anai M; Van Breda E; Hosaka T; Katagiri H; Funaki M; Fukushima Y; Ogihara T; Yazaki Y; Kikuchi ; Oka Y; Asano T
J Biol Chem; 1996 Mar; 271(10):5317-20. PubMed ID: 8621382
[TBL] [Abstract][Full Text] [Related]
57. Mitogenic and metabolic effects of type I IGF receptor overexpression in insulin receptor-deficient hepatocytes.
Kim JJ; Park BC; Kido Y; Accili D
Endocrinology; 2001 Aug; 142(8):3354-60. PubMed ID: 11459778
[TBL] [Abstract][Full Text] [Related]
58. Selective insulin resistance in the polycystic ovary syndrome.
Book CB; Dunaif A
J Clin Endocrinol Metab; 1999 Sep; 84(9):3110-6. PubMed ID: 10487672
[TBL] [Abstract][Full Text] [Related]
59. Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture.
Sakai K; Lowman HB; Clemmons DR
J Biol Chem; 2002 Apr; 277(16):13620-7. PubMed ID: 11834727
[TBL] [Abstract][Full Text] [Related]
60. Changes in phosphatidylinositol 3-kinase 55 kDa gamma expression and subcellular localization may be caspase 6 dependent in paraquat-induced SH-SY5Y apoptosis.
Zhou Y; Li F; Tian X; Wang B; Ding M; Pang H
Hum Exp Toxicol; 2014 Jul; 33(7):761-71. PubMed ID: 24130211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
